BIOA-B.STBIOA-B.STSTO
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +818.32% | +4251.06% | +686.69% | +74.00% | +81.79% |
| Gross Profit Growth | +0.00% | +4564.34% | +725.24% | +76.71% | +89.04% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.08% | +0.16% | +0.23% | +0.26% | -0.12% |
| Weighted Average Shares Diluted Growth | +0.08% | +0.31% | +0.22% | +0.26% | -0.12% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -121.48% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -122.81% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +572.18% | +0.00% | +0.00% | +0.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -6.27% | +86.84% | +105.81% | +137.96% | +131.65% |
| Book Value per Share Growth | -14.56% | +94.50% | +118.59% | +113.82% | +120.05% |
| Debt Growth | +989.13% | +1080.37% | -17.94% | -17.41% | +33.54% |
| R&D Expense Growth | +237.84% | +34.40% | +33.99% | +39.70% | -11.87% |
| SG&A Expenses Growth | -18.92% | +18.52% | +32.78% | +89.24% | +6.37% |